tetano
Editor, Senior Moderator
Viruses
. 2022 Feb 18;14(2):429.
doi: 10.3390/v14020429.
Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
Hae-Ji Kang[SUP] 1 [/SUP], Ki-Back Chu[SUP] 2 [/SUP], Keon-Woong Yoon[SUP] 1 [/SUP], Gi-Deok Eom[SUP] 1 [/SUP], Jie Mao[SUP] 1 [/SUP], Min-Ju Kim[SUP] 1 [/SUP], Su-Hwa Lee[SUP] 2 [/SUP], Eun-Kyung Moon[SUP] 2 [/SUP], Fu-Shi Quan[SUP] 2 3 [/SUP]
Affiliations
Abstract
Avian influenza virus remains a threat for humans, and vaccines preventing both avian and human influenza virus infections are needed. Since virus-like particles (VLPs) expressing single neuraminidase (NA) subtype elicited limited heterosubtypic protection, VLPs expressing multiple NA subtypes would enhance the extent of heterosubtypic immunity. Here, we generated avian influenza VLP vaccines displaying H5 hemagglutinin (HA) antigen with or without avian NA subtypes (N1, N6, N8) in different combinations. BALB/c mice were intramuscularly immunized with the VLPs to evaluate the resulting homologous and heterosubtypic immunity upon challenge infections with the avian and human influenza viruses (A/H5N1, A/H3N2, A/H1N1). VLPs expressing H5 alone conferred homologous protection but not heterosubtypic protection, whereas VLPs co-expressing H5 and NA subtypes elicited both homologous and heterosubtypic protection against human influenza viruses in mice. We observed that VLP induced neuraminidase inhibitory activities (NAI), virus-neutralizing activity, and virus-specific antibody (IgG, IgA) responses were strongly correlated with the number of different NA subtype expressions on the VLPs. VLPs expressing all 3 NA subtypes resulted in the highest protection, indicated by the lowest lung titer, negligible body weight changes, and survival in immunized mice. These results suggest that expressing multiple neuraminidases in avian HA VLPs is a promising approach for developing a universal influenza A vaccine against avian and human influenza virus infections.
Keywords: avian influenza virus; heterosubtypic immunity; neuraminidase; virus-like particles.
. 2022 Feb 18;14(2):429.
doi: 10.3390/v14020429.
Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
Hae-Ji Kang[SUP] 1 [/SUP], Ki-Back Chu[SUP] 2 [/SUP], Keon-Woong Yoon[SUP] 1 [/SUP], Gi-Deok Eom[SUP] 1 [/SUP], Jie Mao[SUP] 1 [/SUP], Min-Ju Kim[SUP] 1 [/SUP], Su-Hwa Lee[SUP] 2 [/SUP], Eun-Kyung Moon[SUP] 2 [/SUP], Fu-Shi Quan[SUP] 2 3 [/SUP]
Affiliations
- PMID: 35216022
- PMCID: PMC8875606
- DOI: 10.3390/v14020429
Abstract
Avian influenza virus remains a threat for humans, and vaccines preventing both avian and human influenza virus infections are needed. Since virus-like particles (VLPs) expressing single neuraminidase (NA) subtype elicited limited heterosubtypic protection, VLPs expressing multiple NA subtypes would enhance the extent of heterosubtypic immunity. Here, we generated avian influenza VLP vaccines displaying H5 hemagglutinin (HA) antigen with or without avian NA subtypes (N1, N6, N8) in different combinations. BALB/c mice were intramuscularly immunized with the VLPs to evaluate the resulting homologous and heterosubtypic immunity upon challenge infections with the avian and human influenza viruses (A/H5N1, A/H3N2, A/H1N1). VLPs expressing H5 alone conferred homologous protection but not heterosubtypic protection, whereas VLPs co-expressing H5 and NA subtypes elicited both homologous and heterosubtypic protection against human influenza viruses in mice. We observed that VLP induced neuraminidase inhibitory activities (NAI), virus-neutralizing activity, and virus-specific antibody (IgG, IgA) responses were strongly correlated with the number of different NA subtype expressions on the VLPs. VLPs expressing all 3 NA subtypes resulted in the highest protection, indicated by the lowest lung titer, negligible body weight changes, and survival in immunized mice. These results suggest that expressing multiple neuraminidases in avian HA VLPs is a promising approach for developing a universal influenza A vaccine against avian and human influenza virus infections.
Keywords: avian influenza virus; heterosubtypic immunity; neuraminidase; virus-like particles.